PETS PetMed Express, Inc. - Common Stock
NASDAQ · Retail · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 13, 2026PETS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
PETS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Acerca de PetMed Express, Inc. - Common Stock Descripción general de la empresa de Wikipedia
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | PETS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.0promedio 5A ≈9.3 | ≈9.3 | · | · | |
| P/S (TTM) | 0.2promedio 5A ≈0.3 | ≈0.3 | 0.2 | Valor razonable | |
| P/C (MRQ) | 1.3promedio 5A ≈1.2 | ≈1.2 | · | · | |
| Precio / FCF (TTM) | -1.1promedio 5A ≈-247.6 | ≈-247.6 | · | · | |
| Precio / Flujo de Caja (TTM) | -1.2promedio 5A ≈13.4 | ≈13.4 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 1.7promedio 5A ≈2.2 | ≈2.2 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | PETS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Bruto (TTM) | 27.9%promedio 5A ≈28.5% | ≈28.5% | 36.4% | Débil | |
| Margen Operativo (TTM) | -18.2%promedio 5A ≈-8.5% | ≈-8.5% | -1.3% | Débil | |
| Margen EBITDA (TTM) | -12.7%promedio 5A ≈-5.8% | ≈-5.8% | -1.3% | Débil | |
| Margen antes de impuestos (TTM) | -17.4%promedio 5A ≈-7.9% | ≈-7.9% | -2.0% | Débil | |
| Margen de Beneficio Neto (TTM) | -17.3%promedio 5A ≈-8.9% | ≈-8.9% | -2.0% | Débil | |
| ROA (TTM) | -33.7%promedio 5A ≈-19.4% | ≈-19.4% | -13.0% | Débil | |
| ROE (TTM) | -78.6%promedio 5A ≈-38.2% | ≈-38.2% | 12.9% | Débil | |
| ROIC | -202.5%promedio 5A ≈-77.2% | ≈-77.2% | -31.5% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | PETS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 0.7promedio 5A ≈1.1 | ≈1.1 | 1.3 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 0.4promedio 5A ≈0.7 | ≈0.7 | 0.3 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | PETS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -21.1%promedio 5A ≈-9.2% | ≈-9.2% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -10.2%promedio 5A ≈-6.5% | ≈-6.5% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -10.0% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | PETS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 1.6promedio 5A ≈1.5 | ≈1.5 | 1.5 | En línea | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 84.7promedio 5A ≈92.6 | ≈92.6 | 84.7 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$947.2K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años
| Fecha ex-dividendo | Monto | Moneda | Rendimiento |
|---|---|---|---|
| Ago 11, 2023 | $0,30 | USD | ≈9.4% |
| Jun 5, 2023 | $0,30 | USD | ≈8.2% |
| Feb 16, 2023 | $0,30 | USD | ≈6.1% |
| Nov 17, 2022 | $0,30 | USD | ≈6.3% |
| Ago 11, 2022 | $0,30 | USD | ≈5.4% |
| May 19, 2022 | $0,30 | USD | ≈5.9% |
| Feb 4, 2022 | $0,30 | USD | ≈5.0% |
| Nov 5, 2021 | $0,30 | USD | ≈3.8% |
| Ago 5, 2021 | $0,30 | USD | ≈4.0% |
| May 13, 2021 | $0,30 | USD | ≈4.1% |
| Ene 29, 2021 | $0,28 | USD | ≈2.9% |
| Nov 6, 2020 | $0,28 | USD | ≈3.7% |
| Jul 30, 2020 | $0,28 | USD | ≈3.5% |
| May 14, 2020 | $0,28 | USD | ≈3.4% |
| Ene 31, 2020 | $0,27 | USD | ≈4.3% |
| Nov 1, 2019 | $0,27 | USD | ≈4.7% |
| Ago 1, 2019 | $0,27 | USD | ≈6.7% |
| May 16, 2019 | $0,27 | USD | ≈5.5% |
| Feb 1, 2019 | $0,27 | USD | ≈4.6% |
| Nov 2, 2018 | $0,27 | USD | ≈3.7% |
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 31 de marzo de 2027 | Ago 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 de diciembre de 2026 | Jun 2, 2026 | $-0.19 | $-0.18 | -3.5% |
| 30 de junio de 2026 | Ago 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31 de marzo de 2026 | $-0.19 | $-0.18 | -3.5% | |
| 31 de diciembre de 2025 | $-0.50 | $-0.06 | -717.0% | |
| 30 de junio de 2025 | $-1.65 | $-0.07 | -2210.9% | |
| 31 de marzo de 2025 | $-0.56 | $-0.05 | -1129.2% | |
| 31 de diciembre de 2024 | $-0.03 | $-0.01 | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Balance general
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Flujo de Efectivo
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Eficiencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Por Acción
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | $4.12 | $4.57 | · | $6.78 | $6.97 | $6.45 | $6.51 | $5.62 | · | · | · | |
| Revenue / Share | $8.56 | $11.02 | $13.78 | $12.62 | $13.43 | $15.37 | · | · | $13.40 | · | · | · | |
| Cash Flow / Share | $-1.36 | $0.23 | $0.21 | $1.37 | $0.91 | $1.99 | $1.94 | $2.20 | $1.83 | · | · | · | |
| Cash / Share | $1.00 | $2.65 | $2.61 | · | $5.29 | $5.86 | $5.15 | $4.86 | $3.78 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 | $0.85 | $0.76 | $0.72 | · | |
| EPS (TTM) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.80 |
Tasas de Crecimiento
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Estado de resultados
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,597,807 | 20,513,281 | · | 20,425,282 | 20,382,979 | 20,332,526 | · | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,938,817 | 20,941,505 | · | 20,425,282 | 20,780,455 | 20,332,526 | · | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Balance general
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Eficiencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Por Acción
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.06 | · | $1.53 | $2.05 | $2.47 | · | $4.66 | $4.67 | $4.54 | · | $4.73 | $4.75 | $4.92 | · | $6.34 | $6.55 | |
| Revenue / Share | $1.89 | · | $1.94 | $2.12 | $2.47 | · | $2.57 | $2.85 | $3.24 | · | $3.20 | $3.42 | $3.85 | · | $2.90 | $3.21 | |
| Cash Flow / Share | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.41 | · | · | · | $0.03 | · | · | · | |
| Cash / Share | $0.60 | · | $1.26 | $1.72 | $1.97 | · | $2.43 | $2.52 | $2.23 | · | $2.34 | $2.53 | $2.91 | · | $4.86 | $4.58 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | |
| EPS (TTM) | $-1.37 | · | $-3.12 | $-2.65 | $-2.13 | · | $0.02 | $-0.05 | $-0.13 | · | $-0.14 | $-0.05 | $0.06 | · | $0.44 | $0.66 |
Valoración (TTM)
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $169M | · | $187M | $198M | $212M | · | $236M | $247M | $259M | · | $262M | $256M | $250M | · | $253M | $256M | |
| Net Income TTM | $-29M | · | $-65M | $-55M | $-44M | · | $357.0K | $-963.0K | $-3M | · | $-3M | $-849.0K | $1M | · | $9M | $13M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -1.4 | · | -1.0 | -0.9 | -1.6 | · | 241.0 | -73.6 | -31.2 | · | -54.0 | -205.0 | 229.8 | · | 40.2 | 29.6 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.2 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| Dividend Yield | 0.05% | · | 0.04% | 0.05% | 0.11% | · | 0.19% | 0.27% | 7.8% | · | 11.8% | 11.5% | 8.5% | · | 6.6% | 5.9% | |
| Earnings Yield | -71.4% | · | -97.5% | -105.6% | -64.2% | · | 0.41% | -1.4% | -3.2% | · | -1.8% | -0.49% | 0.44% | · | 2.5% | 3.4% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · | |
| Annual Payout | $20.0K | · | $29.0K | $29.0K | $78.0K | · | $194.0K | $208.0K | $6M | · | $19M | $25M | $25M | · | $24M | $24M |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Ingresos | $179M | $227M | $274M | $248M | · |
| Margen Bruto % | 28.1% | 30.5% | 28.0% | 27.6% | · |
| Margen Operativo % | -32.8% | -0.67% | -2.9% | 2.4% | · |
| Beneficio neto | $-57M | $-6M | $-7M | $5M | · |
| EPS Diluido | $-2.74 | $-0.30 | $-0.37 | $0.25 | · |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 0.8 | 1.3 | 1.3 | · | · |
| Ratio Rápido | 0.4 | 0.9 | 0.8 | · | · |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-33M | $-395.0K | $-194.0K | $23M | · |
Propietarios institucionales (13F) 53 declarantes · $11.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 10 (0 vs trimestre anterior) | 8 (-2 vs trimestre anterior) | 9 (-1 vs trimestre anterior) | 18 (+2 vs trimestre anterior) | -1.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3 084 028 | 963 759 | 26,00% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $2 171 962 | 1 131 230 | 18,31% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 588 602 | 827 397 | 13,39% | Acciones |
| BlackRock, Inc. | $1 091 050 | 568 255 | 9,20% | Acciones |
| FEDERATED HERMES, INC. | $407 367 | 212 170 | 3,43% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $391 947 | 204 075 | 3,30% | Acciones |
| STEEL PARTNERS HOLDINGS L.P. | $371 835 | 193 664 | 3,13% | Acciones |
| UBS Group AG | $265 594 | 138 330 | 2,24% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232 412 | 121 048 | 1,96% | Acciones |
| Rangeley Capital, LLC | $232 320 | 121 000 | 1,96% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $212 124 | 110 481 | 1,79% | Acciones |
| STATE STREET CORP | $201 932 | 105 173 | 1,70% | Acciones |
| Formidable Asset Management, LLC | $195 056 | 85 551 | 1,64% | Acciones |
| Empowered Funds, LLC | $158 108 | 82 348 | 1,33% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $156 301 | 81 407 | 1,32% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152 646 | 79 503 | 1,29% | Acciones |
| CITADEL ADVISORS LLC | $142 324 | 74 127 | 1,20% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $115 811 | 60 353 | 0,98% | Acciones |
| UMB Bank, n.a. | $115 200 | 60 000 | 0,97% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91 647 | 47 733 | 0,77% | Acciones |
| NORTHERN TRUST CORP | $81 893 | 42 653 | 0,69% | Acciones |
| XTX Topco Ltd | $80 511 | 41 933 | 0,68% | Acciones |
| CIBC Private Wealth Group LLC | $75 300 | 30 000 | 0,63% | Acciones |
| SIMPLEX TRADING, LLC | $47 702 | 24 845 | 0,40% | Acciones |
| IMC-Chicago, LLC | $44 014 | 22 924 | 0,37% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $29 568 | 15 400 | 0,25% | Opción de compra |
| Jain Global LLC | $26 148 | 13 619 | 0,22% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $24 712 | 12 871 | 0,21% | Acciones |
| MORGAN STANLEY | $22 282 | 11 604 | 0,19% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $17 637 | 9 186 | 0,15% | Acciones |
| Vanguard Global Advisers, LLC | $15 590 | 8 120 | 0,13% | Acciones |
| OSAIC HOLDINGS, INC. | $6 772 | 3 527 | 0,06% | Acciones |
| SBI Securities Co., Ltd. | $2 148 | 1 119 | 0,02% | Acciones |
| Bank & Trust Co | $2 054 | 901 | 0,02% | Acciones |
| HARBOUR INVESTMENTS, INC. | $1 037 | 540 | 0,01% | Acciones |
| Accredited Wealth Management, LLC | $1 004 | 5 636 | 0,01% | Acciones |
| Allworth Financial LP | $949 | 494 | 0,01% | Acciones |
| MCF Advisors LLC | $768 | 400 | 0,01% | Acciones |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0,01% | Acciones |
| Ascentis Independent Advisors | $683 | 356 | 0,01% | Acciones |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0,00% | Acciones |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0,00% | Acciones |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0,00% | Acciones |
| Farther Finance Advisors, LLC | $290 | 151 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129 933 | 0,00% | Acciones |
| FMR LLC | $115 | 60 | 0,00% | Acciones |
| Elevated Capital Advisors, LLC | $96 | 50 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0,00% | Acciones |
| CITIGROUP INC | $17 | 9 | 0,00% | Acciones |
| CoreCap Advisors, LLC | $8 | 4 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 presentaciones | 29 de junio de 2026 | 12,07% | Enmienda | Inversión pasiva | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | 11 de febrero de 2026 | 1,83% | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 29 insiders · 8 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jeffrey Allen Willard | CEO and President | 28 de septiembre de 2026 A | 250 000 | 0 | 0 | $0 |
| Leslie C.G. Campbell | Interim CEO and President | 11 de agosto de 2026 A | 145 000 | 0 | 0 | $0 |
| Sandra Yvette Campos | CEO & President | 30 de abril de 2025 S | 578 524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | 27 de enero de 2021 S | 337 800 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | 26 de junio de 2026 A | 102 500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | 27 de septiembre de 2024 A | 250 000 | 0 | 0 | $0 |
| Christine Chambers | CFO | 31 de mayo de 2024 D | 65 146 | 0 | 0 | $0 |
| Bruce S Rosenbloom | Chief Financial Officer | 30 de julio de 2021 A | 45 450 | 0 | 0 | $0 |
| Tamar Elkeles | Consejero | 17 de septiembre de 2026 A | 49 923 | 0 | 0 | $0 |
| Peter Batushansky | Consejero | 11 de agosto de 2026 A | 91 928 | 0 | 0 | $0 |
| Justin L. Mennen | Consejero | 11 de agosto de 2026 A | 98 274 | 0 | 0 | $0 |
| Gian Fulgoni | Consejero | 21 de enero de 2026 D | 132 299 | 0 | 0 | $0 |
| Leah Solivan | Consejero | 30 de octubre de 2025 A | 42 289 | 0 | 0 | $0 |
| Diana G Purcel | Consejero | 8 de agosto de 2024 A | 24 375 | 0 | 0 | $0 |
| Jodi Watson | Consejero | 28 de julio de 2022 A | 18 880 | 0 | 0 | $0 |
| Peter Cobb | Consejero | 28 de julio de 2022 A | 15 000 | 0 | 0 | $0 |
| Ronald J Korn | Consejero | 30 de julio de 2021 A | 90 833 | 0 | 0 | $0 |
| Frank J Formica | Consejero | 29 de enero de 2021 S | 55 000 | 0 | 0 | $0 |
| Robert C Schweitzer | Consejero | 28 de agosto de 2020 S | 95 834 | 0 | 0 | $0 |
| Marc Puleo MD | Consejero | 16 de agosto de 2005 J | 913 286 | 0 | 0 | $0 |
| SilverCape Investments Limited | Propietario del 10% | 13 de agosto de 2025 P | 2 579 696 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | Propietario del 10% | 4 de agosto de 2006 S | 2 284 000 | 0 | 0 | $0 |
| James Lacamp | · | 11 de agosto de 2026 A | 90 421 | 0 | 0 | $0 |
| Jacqueline Paula Smith | · | 15 de enero de 2025 A | 28 099 | 0 | 0 | $0 |
| Mathew N Hulett | · | 29 de abril de 2024 D | 103 850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | · | 11 de diciembre de 2023 A | 42 000 | 0 | 0 | $0 |
| Daniel Job Pingree | · | 17 de mayo de 2023 A | 22 000 | 0 | 0 | $0 |
| CRESLIN LTD | · | 4 de agosto de 2006 S | 2 284 000 | 0 | 0 | $0 |
| Guven Kivilcim | · | 22 de enero de 2004 S | 1 310 300 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 20 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EWUS · iShares Trust | 0,25% | 37 222 SH | 11 de septiembre de 2026 | Diario |
| ISVL · iShares Trust | 0,17% | 202 554 SH | 11 de septiembre de 2026 | Diario |
| ISCF · iShares Trust | 0,09% | 216 018 SH | 11 de septiembre de 2026 | Diario |
| IEUS · iShares Trust | 0,07% | 45 419 SH | 11 de septiembre de 2026 | Diario |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,05% | 58 613 SH | 2 de octubre de 2026 | Diario |
| SCZ · iShares Trust | 0,03% | 1 496 647 SH | 11 de septiembre de 2026 | Diario |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 1 566 925 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 26 193 SH | 11 de septiembre de 2026 | Diario |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 1 056 528 SH | 19 de agosto de 2026 | Diario |
| IEUR · iShares Trust | 0,01% | 291 699 SH | 11 de septiembre de 2026 | Diario |
| IWC · iShares Trust | 0,01% | 51 213 SH | 11 de septiembre de 2026 | Diario |
| IEFA · iShares Trust | 0,00% | 3 372 753 SH | 11 de septiembre de 2026 | Diario |
| IDEV · iShares Trust | 0,00% | 546 389 SH | 11 de septiembre de 2026 | Diario |
| IXUS · iShares Trust | 0,00% | 684 652 SH | 11 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 211 088 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 602 795 SH | 19 de agosto de 2026 | Diario |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 6 557 275 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 341 189 SH | 19 de agosto de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 4 366 658 SH | 19 de agosto de 2026 | Diario |
| VSGX · VANGUARD WORLD FUND | 0,00% | 78 854 SH | 19 de agosto de 2026 | Diario |
PETS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
1 analistas · 2026-10-01Objetivo medio $1.40 +2,9%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PETS | $49M | -0.8 | -21.1% | -32.0% | -100.4% | 28.1% |
| RENT | · | 3.7 | 7.7% | 6.9% | -16.9% | · |
| GROV | $46M | -3.2 | -14.6% | -6.7% | 75.6% | 53.7% |
| SPWH | $52M | -1.1 | 0.96% | -4.1% | -25.2% | 30.9% |
| LESL | $46M | -0.2 | -6.6% | -19.1% | 70.0% | 35.4% |
| ULTA | $27.83B | 24.6 | 9.7% | 9.3% | 42.7% | 39.1% |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.